Carfilzomib Injection

Product Description

Carfilzomib injection is used alone and in combination with dexamethasone, daratumumab and dexamethasone, or lenalidomide (revlimid) and dexamethasone to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with other medications. Carfilzomib is in a class of medications called proteasome inhibitors. It works by stopping or slowing the growth of cancer cells in your body. Themost common side effects of this medicine include tiredness, headache, weakness, diarrhea, constipation, muscle spasm, pain in the arms or legs. Carfilzomib injection should be refrigerated at 2 to 8c (36 to 46f) to preserve potency. Do not freeze.